| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 158, Issue 12 5797-5804, Copyright © 1997 by American Association of Immunologists
ARTICLES |
W Wang, PH Gulden, RA Pierce, J Shabanowitz, ST Man, DF Hunt, VH Engelhard and J] Shabanowitz JA$[corrected to Shabanowitz
Department of Microbiology and the Beirne Carter Center for Immunology Research, University of Virginia, Charlottesville 22901, USA.
In contrast to T cells that respond to peptides presented by self MHC molecules, alloreactive T cells recognize determinants expressed on nonself MHC molecules. Because current positive selection models suggest that T cell affinity toward a nonself MHC molecule would be lower than that toward a self MHC molecule, we previously proposed that vigorous alloreactive responses would be generated preferentially toward those antigenic peptide complexes presented at the highest density on the cell surface. The high abundance of two class I MHC- associated peptides that have been identified as allo- or xenoantigens is consistent with this hypothesis. We report here the identification of a naturally processed peptide YLDPAQQNL that is presented by HLA- A*0201 and recognized by an alloreactive T cell clone. This peptide appears to originate from an unknown member of the zinc finger proteins. Quantitation by mass spectrometry indicates that this peptide is present on the surface at 85 to 125 copies per cell, comparable with the density of several other epitopes presented by HLA-A*0201 to self MHC-restricted T cells. In addition, based on the affinity of the peptide for HLA-A*0201 and the half-maximal peptide concentration required for T cell sensitization, this alloreactive T cell appears to have an affinity similar to or higher than that of many self MHC- restricted T cells. These data suggest that allogeneic responses can be directed against antigenic determinants of low abundance and that recognition of alloreactive peptides is not limited by a lower affinity of T cells for nonself MHC molecules.
This article has been cited by other articles:
|
|
 |
|
  M. A. Purbhoo, D. H. Sutton, J. E. Brewer, R. E. Mullings, M. E. Hill, T. M. Mahon, J. Karbach, E. Jager, B. J. Cameron, N. Lissin, et al. Quantifying and Imaging NY-ESO-1/LAGE-1-Derived Epitopes on Tumor Cells Using High Affinity T Cell Receptors. J. Immunol., June 15, 2006; 176(12): 7308 - 7316. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. J. Felix, A. Suri, J. J. Walters, S. Horvath, M. L. Gross, and P. M. Allen I-Ep-Bound Self-Peptides: Identification, Characterization, and Role in Alloreactivity J. Immunol., January 15, 2006; 176(2): 1062 - 1071. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. E. Clark and R. H. Vonderheide Getting to the Surface: A Link Between Tumor Antigen Discovery and Natural Presentation of Peptide-MHC Complexes Clin. Cancer Res., August 1, 2005; 11(15): 5333 - 5336. [Full Text] [PDF]
|
|
|
|
|
|
D. Palliser, H. Ploegh, and M. Boes Myeloid Differentiation Factor 88 Is Required for Cross-Priming In Vivo J. Immunol., March 15, 2004; 172(6): 3415 - 3421. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T.-H. Yang, M. Lovatt, M. Merkenschlager, and H. J. Stauss Comparison of the frequency of peptide-specific cytotoxic T lymphocytes restricted by self- and allo-MHC following in vitro T cell priming Int. Immunol., November 1, 2002; 14(11): 1283 - 1290. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Velazquez, R. DiPaolo, and E. R. Unanue Quantitation of Lysozyme Peptides Bound to Class II MHC Molecules Indicates Very Large Differences in Levels of Presentation J. Immunol., May 1, 2001; 166(9): 5488 - 5494. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Garcia-Peydro, A. Paradela, J. P. Albar, and J. A. L. d. Castro Antagonism of Direct Alloreactivity of an HLA-B27-Specific CTL Clone by Altered Peptide Ligands of Its Natural Epitope J. Immunol., November 15, 2000; 165(10): 5680 - 5685. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Zavazava and D. Kabelitz Alloreactivity and apoptosis in graft rejection and transplantation tolerance J. Leukoc. Biol., August 1, 2000; 68(2): 167 - 174. [Abstract] [Full Text]
|
|
|
|
 |
|
 R. Obst, N. Netuschil, K. Klopfer, S. Stevanovi, and H.-G. Rammensee The Role of Peptides in T Cell Alloreactivity Is Determined by Self-Major Histocompatibility Complex Molecules J. Exp. Med., March 6, 2000; 191(5): 805 - 812. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Loyer, P. Fontaine, S. Pion, F. Hetu, D.-C. Roy, and C. Perreault The In Vivo Fate of APCs Displaying Minor H Antigen and/or MHC Differences Is Regulated by CTLs Specific for Immunodominant Class I-Associated Epitopes J. Immunol., December 15, 1999; 163(12): 6462 - 6467. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Garcia-Peydro, A. Paradela, J. R. Lamas, and J. A. Lopez de Castro Peptide Presentation to an Alloreactive CTL Clone Is Modulated Through Multiple Mechanisms Involving Polymorphic and Conserved Residues in HLA-B27 J. Immunol., December 1, 1999; 163(11): 6060 - 6064. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Grakoui, S. K. Bromley, C. Sumen, M. M. Davis, A. S. Shaw, P. M. Allen, and M. L. Dustin The Immunological Synapse: A Molecular Machine Controlling T Cell Activation Science, July 9, 1999; 285(5425): 221 - 227. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. Pion, G. J. Christianson, P. Fontaine, D. C. Roopenian, and C. Perreault Shaping the Repertoire of Cytotoxic T-Lymphocyte Responses: Explanation for the Immunodominance Effect Whereby Cytotoxic T Lymphocytes Specific for Immunodominant Antigens Prevent Recognition of Nondominant Antigens Blood, February 1, 1999; 93(3): 952 - 962. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Munz, R. Obst, W. Osen, S. Stevanovic, and H.-G. Rammensee Alloreactivity as a Source of High Avidity Peptide-Specific Human CTL J. Immunol., January 1, 1999; 162(1): 25 - 34. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Gugasyan, I. Vidavsky, C. A. Nelson, M. L. Gross, and E. R. Unanue Isolation and Quantitation of a Minor Determinant of Hen Egg White Lysozyme Bound to I-Ak by Using Peptide-Specific Immunoaffinity J. Immunol., December 1, 1998; 161(11): 6074 - 6083. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Paradela, M. Garcia-Peydro, J. Vazquez, D. Rognan, and J. A. Lopez de Castro The Same Natural Ligand Is Involved in Allorecognition of Multiple HLA-B27 Subtypes by a Single T Cell Clone: Role of Peptide and the MHC Molecule in Alloreactivity J. Immunol., November 15, 1998; 161(10): 5481 - 5490. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Shi, K. D. Smith, and C. T. Lutz TAP-Independent MHC Class I Peptide Antigen Presentation to Alloreactive CTL Is Enhanced by Target Cell Incubation at Subphysiologic Temperatures J. Immunol., May 1, 1998; 160(9): 4305 - 4312. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Wang, S. Man, P. H. Gulden, D. F. Hunt, and V. H. Engelhard Class I-Restricted Alloreactive Cytotoxic T Lymphocytes Recognize a Complex Array of Specific MHC-Associated Peptides J. Immunol., February 1, 1998; 160(3): 1091 - 1097. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
